The estimated Net Worth of Mitch C. Hill, is at least $16 Milion dollars as of 12 August 2024. Mr Hill owns over 5,000 units of Inari Medical stock worth over $8,319,922 and over the last 4 years he sold NARI stock worth over $7,660,893.
Sign up
Mr Hill NARI stock SEC Form 4 insiders trading
Mr has made over 46 trades of the Inari Medical stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 5,000 units of NARI stock worth $2,300 on 12 August 2024.
The largest trade he's ever made was exercising 131,893 units of Inari Medical stock on 12 March 2023 worth over $2,638. On average, Mr trades about 8,668 units every 24 days since 2020. As of 12 August 2024 he still owns at least 184,600 units of Inari Medical stock.
You can see the complete history of Mr Hill stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Mitchell C. Hill biography
Mitchell C. Hill is the Chief Financial Officer at Inari Medical.
How old is Mr Hill?
Mr Hill is 62, he's been the Chief Financial Officer of Inari Medical since . There are no older and 4 younger executives at Inari Medical.
What's Mr Hill's mailing address?
Mitch's mailing address filed with the SEC is C/O INARI MEDICAL, INC., 6001 OAK CANYON, IRVINE, CA, 92618.
Insiders trading at Inari Medical
Over the last 4 years, insiders at Inari Medical have traded over $519,947,508 worth of Inari Medical stock and bought 1,100,480 units worth $22,863,324 . The most active insiders traders include Gilde Healthcare Iv U.A.Gil..., William Hoffman a Andrew Hykes. On average, Inari Medical executives and independent directors trade stock every 7 days with the average trade being worth of $1,998,809. The most recent stock trade was executed by Andrew Hykes on 20 August 2024, trading 3,000 units of NARI stock currently worth $150,000.
What does Inari Medical do?
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
What does Inari Medical's logo look like?
Complete history of Mr Hill stock trades at Inari Medical
Inari Medical executives and stock owners
Inari Medical executives and other stock owners filed with the SEC include:
-
William H. Hoffman,
CEO, Pres & Director -
Dr. Thomas M. Tu M.D.,
Chief Medical Officer -
Andrew J. Hykes,
Chief Operating Officer -
John R. Borrell,
VP of Sales -
Eric Khairy,
VP Marketing -
Angela Ahmad,
Gen. Counsel -
Janet Byk,
VP of Fin. & Accounting -
Mitchell C. Hill,
Chief Financial Officer -
Robert Keith Warner,
Director -
Kirk G. Nielsen,
Director -
Jonathan D Root,
Director -
Dana G Jr. Mead,
Director -
Gilde Healthcare Iv U.A.Gil...,
-
Management Group X Llcus Ve...,
-
Catherine M. Szyman,
Director -
Management Group X Llcus Ve...,
-
Thomas Tu,
Chief Medical Officer -
Ventures Iv, Llc Versant Ve...,
-
Geoffrey B Pardo,
Director -
Mitch C. Hill,,
Chief Financial Officer -
Rebecca Chambers,
Director -
Cynthia L Lucchese,
Director -
William Hoffman,
Director -
Donald B Milder,
Director